Filter browse results

Total results with these characteristics: 24

Subject: Vaccines and immunization > Japanese encephalitis

Page 1 of 2
Advanced Immunization Management (AIM) e-Learning Website: Japanese Encephalitis

The AIM e-Learning tool is designed to provide comprehensive information to support immunization program managers at all stages of country-level decision-making. This module will help senior policymakers understand Japanese encephalitis (JE) and how immunization programs can decrease JE infection among people. It also provides information on how to add JE vaccine to an immunization program and how to manage the addition of a new vaccine.

Publication date: 2010

Region: Asia

Part of series: AIM e-Learning modules

Creating a Japanese Encephalitis Surveillance System in Vietnam

This document provides details on PATH's partnership with the National Expanded Program on Immunization in Vietnam to enhance surveillance of Japanese encephalitis disease and inform planning for immunization programs.

Author: Phillips D

Publication date: May 2007

Region: Asia

Directions in Global Health (Volume 2, Issue 3)

The December 2005 issue of Directions in Global Health features five projects: PATH's Japanese encephalitis project, our collaboration with WHO on gender-based violence, a "lab-on-a-card" technology for detecting enteric disease, new HPV DNA tests for detecting cervical cancer, and an innovative behavior-change project that is helping prevent HIV in Eritrea.

Author: PATH

Publication date: December 2005

Region: Global

Part of series: Directions in Global Health

Directions in Global Health (Volume 5, Issue 1)

This issue of Directions in Global Health profiles our effort to expand access to safe water, particularly in India; a project to improve nutrition for infants and young children; our thermostable vaccine work; surveillance activities for Japanese encephalitis; and our work under the Reproductive Health Supplies Coalition.

Publication date: May 2008

Region: Global

Part of series: Directions in Global Health

Directions in Global Health (Volume 6, Issue 2)

This issue of Directions in Global Health showcases PATH’s global presence. It highlights work related to influenza in Africa, HIV and AIDS in Eastern Europe,  Japanese encephalitis in Asia, gender-based violence in Latin America and the Caribbean, and diagnostic technologies in North America. The back cover features a map and summary information on PATH’s work around the world.

Publication date: August 2009

Region: Global

Part of series: Directions in Global Health

Global Vaccine Action Plan: 2011-2020

The Global Vaccine Action Plan (GVAP)—endorsed by the 194 Member States of the World Health Assembly in May 2012—is a roadmap to prevent millions of deaths by 2020 through more equitable access to vaccines for people in all communities. The GVAP aims to strengthen routine immunization, introduce new and improved vaccines, and advance research and development for the next generation of vaccines and technologies.

Author: Decade of Vaccines Collaboration

Publication date: May 2012

Region: Global

Immunizing Children Against Japanese Encephalitis Using Inactivated, Mouse-brain Derived Japanese Encephalitis Vaccine: A Training Module for Vaccinators

Author: Lasher H; Jacobson J

Publication date: 2003

Region: Global

Immunizing Children against Japanese Encephalitis Using SA 14-14-2 JE Vaccine

Publication date: 2005

Region: Global

Increasing Access to Lifesaving Vaccines: PATH Closes the Immunization Gap Through Innovation and Collaboration

This fact sheet outlines PATH's work on vaccines and immunization. Topic areas include developing affordable vaccines, designing innovative vaccine technologies, and expanding uptake of existing vaccines. These efforts reduce the burden of malaria, meningitis, diarrheal disease, Japanese encephalitis, pneumococcal disease, influenza, and other infectious diseases in developing countries.

Publication date: December 2011

Region: Global

Part of series: PATH's areas of focus fact sheets

Japanese Encephalitis Vaccine Introduction in Cambodia

This fact sheet describes PATH's partnership with Cambodia's Ministry of Health to conduct sentinel surveillance on Japanese encephalitis and introduce a vaccine in 2009.

Publication date: December 2010

Region: Asia

Japanese Encephalitis Vaccines at a Glance

This fact sheet provides a side-by-side comparison of internationally available vaccines against Japanese encephalitis, including information on dosage, cost, and supply.

Author: Hills S

Publication date: 2007

Region: Asia

JE Newsbriefs and JE Flash

JE Newsbriefs was the quarterly newsletter of PATH’s Japanese encephalitis (JE) project (2003–2009). It provided updates on PATH’s work to increase the availability in the developing world of a vaccine against JE—a mosquito-borne illness that can cause severe neurological disability or death. JE Flash served as a supplement between editions of the JE Newsbriefs quarterly newsletter, providing breaking news on JE disease and vaccines. Although PATH’s JE project has closed out activities, these newsletter archives contain helpful information about recent advances and organizations that continue to work toward JE control.

Publication date: 2009

Region: Asia

Kill or Cure? Japanese Encephalitis

The film provides a glimpse of the serious Japanese encephalitis outbreak in India in 2005, along with innovative diagnostic work in Malaysia, and it explains why vaccination is the only effective way to control the disease.

Publication date: 2005

Region: Asia

Part of series: Kill or Cure? videos

Long-Term Immunogenicity of Measles Vaccine After Coadministration With Live Attenuated Japanese Encephalitis Vaccine

This document summarizes the results of a study among children in the Philippines who received both measles and Japanese encephalitis vaccines at nine months of age. Data for this follow-up study were collected one year post-vaccination.

Author: Gatchalian S, Jacobson J, Kelly K, Sutee Y, Yaïch M, Yao Y, Zhang L, Zhou B

Publication date: November 2007

Region: Asia

Measles Vaccine Immunogenicity After Coadministration With Live Attenuated Japanese Encephalitis Vaccine Shows Equivalence to That of Measles Vaccine Given Alone

This study by PATH's Japanese encephalitis (JE) project evaluated whether measles vaccine and the live, attenuated JE vaccine can be safely co-administered with no effect on the immunogenicity of either.

Author: Gatchalian S, Jacobson J, Kelly K, Sutee Y, Yaïch M, Yao Y, Zhang L, Zhou B

Publication date: December 2006

Region: Asia

PATH in China: Joining With Diverse Partners to Create Sustainable Health Solutions

This brochure outlines PATH's work in China, with emphasis on public-private partnerships for product development. Areas of focus include vaccines and immunization, health technologies, and women's health.

Publication date: November 2012

Region: Asia

PATH's Japanese Encephalitis Project: Accomplishments and Lessons Learned

This set of fact sheets details technical activities of PATH's Japanese encephalitis project, with an aim to inform future efforts and programs. The fact sheets were developed as a supplement to PATH's Japanese Encephalitis Project: Collaboration and Commitment to Protect Asia's Children. Topics covered include surveillance of disease burden and disability, cost-effectiveness analysis, diagnostics, advocacy, vaccine development, and vaccine introduction.

Publication date: December 2009

Region: Global

PATH's Japanese Encephalitis Project: Collaboration and Commitment to Protect Asia's Children

This report summarizes the activities and achievements of PATH's Japanese encephalitis project (2003–2009), which aimed to accelerate availability of a safe and efficacious vaccine to vulnerable communities throughout Asia. Technical fact sheets bundled with the report provide guidance on disease surveillance, cost-effectiveness, advocacy, vaccine introduction, and more. The report is available as one large file or as four smaller files for easier downloading.

Publication date: October 2010

Region: Asia

Protecting India's Children From Japanese Encephalitis

This fact sheet provides information about the partnerships and commitments that helped the Government of India introduce a landmark strategy to vaccinate children at highest risk of Japanese encephalitis. Campaigns in 2006 reached more than 9 million children, and the target population in 2007 exceeds 23 million.

Author: Phillips D

Publication date: 2007

Region: Asia

SA 14-14-2 Japanese Encephalitis (JE) Vaccine

This fact sheet provides important information on the SA 14-14-2 JE vaccine manufactured by the Chengdu Institute of Biological Products. Topics include vaccine presentation, dosage, safety, and history of use.

Author: Hills S

Publication date: 2007

Region: Asia

Page 1 of 2